Analysis of GFP+ BM cells prior to injection determined that myeloid, erythroid, T-cell, and lymphatic markers were highly expressed (up to 90%) in vitro (Fig 4B and S2 Fig) suggesting that low or absent expression of CD3e and Ter-119 in tumor-residing M-LECP was due to in vivo induced suppression. This evidence concerns the gene CD3E and neoplasm.